 |
|
Up to 85% of all strokes are of ischaemic origin and mostly due to blockage of a cerebral
artery by a blood clot. After introduction of thrombolytic therapy for the treatment of acute myocardial
infarction in the early 1990s, major trials for the evaluation of this new therapeutic approach to ischaemic
stroke were initiated. A good overview of thrombolytic therapy treatments is given by the book of Fiebach&
Schellinger.
Important aspects in thrombolytic therapy are
|
|
  |
|
© 2005 Boehringer Ingelheim GmbH, Germany. All rights reserved.
|
|
